HCP (HCP) Financial Statements
Historical financial data — 12 statements covering FY2022–FY2024
HCP's revenue increased 22.5% year over year, from $475.9M to $583.1M.
Net income increased 30.5% over the same period, from $-274.3M to $-190.7M.
Operating cash flow grew 87.2% to $-10.9M.
HCP maintains a negative net profit margin of -32.7%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2023 | $214.8M+112.9% | $-153.0M | $173.8M | $-157.1M | $-70.9M | $1.57B | N/A | $1.23B |
| Q3 FY2023 | $340.1M+58.4% | $-224.9M | $276.6M | $-234.4M | $-86.0M | $1.55B | N/A | $1.21B |
| Q1 FY2024 | $138.0M-59.4% | $-53.3M | $111.2M | $-67.8M | $3.9M | $1.58B | N/A | $1.19B |
| Q2 FY2024 | $281.2M+103.8% | $-119.6M | $225.1M | $-150.4M | $-29.8M | $1.59B | N/A | $1.18B |
| Q3 FY2024 | $427.4M+52.0% | $-159.0M | $345.6M | $-206.0M | $-21.1M | $1.59B | N/A | $1.19B |
| Q1 FY2025 | $160.6M-62.4% | $-51.1M | $130.3M | $-67.7M | $28.1M | $1.65B | N/A | $1.21B |
| Q2 FY2025 | $325.7M+102.8% | $-77.6M | $265.2M | $-111.0M | $19.6M | $1.68B | N/A | $1.23B |
| Q3 FY2025 | $499.1M+53.2% | $-90.6M | $408.8M | $-140.9M | $57.7M | $1.69B | N/A | $1.26B |
Balance Sheet Summary (Latest Period)
Total Assets
$1.69B
Total Liabilities
$479.0M
Total Equity
$1.21B
Cash & Equivalents
$1.28B
Total Debt
N/A
Current Assets
$1.54B
Current Liabilities
$440.8M
Retained Earnings
$-971.1M